January 11, 2023 Takis and Rottapharm Biotech announce the advance publication of the article “A first-in-human trial on the safety and immunogenicity of COVID-eVax, a… Read More »COVID-eVax PHASE 1 CLINICAL TRIAL RESULTS PUBLISHED
October 1, 2019 Monza (Italy) – Rottapharm Biotech announces that results from the Phase 2 trial of CR4056 in chronic pain associated with osteoarthritis (OA) have been published… Read More »Rottapharm Biotech’s analgesic CR4056 meets the right OA phenotype
Osteoarthritis Treatment Re-Loaded Yet again, Rottapharm Biotech scientists’ expertise and passion for osteoarthritis trials is at the service of integrated information. Read their outstanding systematic… Read More »Published on JAMA Rottapharm Biotech scientists’ systematic review and meta-analysis on osteoarthritis treatments